T. Rowe Price Investment Management, Inc. Corcept Therapeutics Inc Transaction History
T. Rowe Price Investment Management, Inc.
- $158 Billion
- Q2 2025
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 566,269 shares of CORT stock, worth $41.7 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
566,269Holding current value
$41.7 Million% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding CORT
# of Institutions
466Shares Held
82.7MCall Options Held
489KPut Options Held
1.02M-
Black Rock Inc. New York, NY16.5MShares$1.22 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.68MShares$712 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY7.72MShares$568 Million20.11% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.27MShares$461 Million0.65% of portfolio
-
Parallel Advisors, LLC3.87MShares$285 Million5.83% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $7.88B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...